Black Diamond Therapeutics
BDTX
BDTX
96 hedge funds and large institutions have $212M invested in Black Diamond Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $218M → $212M (-$6.02M)
27% less call options, than puts
Call options by funds: $7.04M | Put options by funds: $9.61M
Holders
96
Holding in Top 10
–
Calls
$7.04M
Puts
$9.61M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$3.04M | |
| 3 | +$3.03M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$2.58M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.24M |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$3.89M | |
| 3 | -$3.38M | |
| 4 |
SC
Stempoint Capital
New York
|
-$3.14M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$3.03M |